je.st
news
Tag: approval
GE's Boiler Treatment Product Receives US FDA Approval
2015-09-10 07:00:58| dairynetwork News Articles
GE announced recently that its Solus AP boiler treatment product has received U.S. Food and Drug Administration (FDA) approval as a secondary direct food additive for use across regulated industries where steam comes in contact with food products.
Tags: product
treatment
approval
receives
GE's Boiler Treatment Product Receives US FDA Approval
2015-09-10 07:00:58| foodingredientsonline News Articles
GE announced recently that its Solus AP boiler treatment product has received U.S. Food and Drug Administration (FDA) approval as a secondary direct food additive for use across regulated industries where steam comes in contact with food products.
Tags: product
treatment
approval
receives
GE secures US and EU approval for 13.9bn Alstom acquisition
2015-09-09 01:00:00| Power Technology
US-based General Electric has secured approval from the European Commission (EC) and US Department of Justice (DOJ) for the 12.5bn ($13.9bn) acquisition of French Alstom's power and grid business.
Tags: approval
acquisition
secures
alstom
Merck and Samsung Bioepis Announce Approval of BRENZYS (Etanercept), a Biosimilar of Enbrel, in Korea
2015-09-08 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & SEOUL, South Korea First Product from Global Partnership to Deliver High-Quality Biosimilars to Help Meet Needs of Patients and Healthcare Systems Worldwide KENILWORTH, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced the approval of BRENZYS (etanercept), a biosimilar of the immunology medicine Enbrel, by the Ministry of Food and Drug Safety (MFDS) in Korea. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879orSamsung BioepisMedia:Jamyung Cha, (82) 32-455-6137orInvestors:Sungjoon Park, (82) 32-455-6120 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
korea
samsung
approval
[Newsmaker] Samsung's first biosimilar drug gains domestic approval
2015-09-08 11:51:41| Biotech - Topix.net
Samsung Group, South Korea's leading conglomerate, has taken a significant step toward driving forward its newly-established biopharmaceuticals business, an emerging sector expected to become one of the company's future growth engines. Samsung Bioepis, the conglomerate's biotechnology research and development unit, said Monday that it had gained approval from the Ministry of Food and Drug Safety to begin selling Brenzys, its biosimilar copy of Pfizer's rheumatoid arthritis treatment Enbrel, in South Korea.
Tags: drug
approval
domestic
gains
Sites : [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] next »